WallStSmart

HealthStream Inc (HSTM)vsVeeva Systems Inc Class A (VEEV)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Veeva Systems Inc Class A generates 977% more annual revenue ($3.46B vs $321.12M). VEEV leads profitability with a 29.3% profit margin vs 6.6%. VEEV appears more attractively valued with a PEG of 1.16. VEEV earns a higher WallStSmart Score of 66/100 (B-).

HSTM

Buy

53

out of 100

Grade: C-

Growth: 6.0Profit: 5.0Value: 3.7Quality: 6.5
Piotroski: 3/9Altman Z: 2.33

VEEV

Strong Buy

66

out of 100

Grade: B-

Growth: 8.7Profit: 8.0Value: 6.7Quality: 9.0
Piotroski: 4/9Altman Z: 4.78
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for HSTM.

VEEVUndervalued (+41.1%)

Margin of Safety

+41.1%

Fair Value

$300.79

Current Price

$280.68

$20.11 discount

UndervaluedFair: $300.79Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

HSTM3 strengths · Avg: 8.7/10
Debt/EquityHealth
0.0410/10

Conservative balance sheet, low leverage

Price/BookValuation
2.4x8/10

Reasonable price relative to book value

EPS GrowthGrowth
28.4%8/10

Earnings expanding 28.4% YoY

VEEV6 strengths · Avg: 8.8/10
Debt/EquityHealth
0.0210/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
4.7810/10

Safe zone — low bankruptcy risk

Profit MarginProfitability
29.3%9/10

Keeps 29 of every $100 in revenue as profit

Operating MarginProfitability
29.6%8/10

Strong operational efficiency at 29.6%

Revenue GrowthGrowth
17.6%8/10

17.6% revenue growth

EPS GrowthGrowth
39.5%8/10

Earnings expanding 39.5% YoY

Areas to Watch

HSTM4 concerns · Avg: 3.0/10
Market CapQuality
$866.38M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
5.9%3/10

ROE of 5.9% — below average capital efficiency

Profit MarginProfitability
6.6%3/10

6.6% margin — thin

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

VEEV1 concerns · Avg: 2.0/10
P/E RatioValuation
42.7x2/10

Premium valuation, high expectations priced in

Comparative Analysis Report

WallStSmart Research

Bull Case : HSTM

The strongest argument for HSTM centers on Debt/Equity, Price/Book, EPS Growth. Revenue growth of 12.5% demonstrates continued momentum.

Bull Case : VEEV

The strongest argument for VEEV centers on Debt/Equity, Altman Z-Score, Profit Margin. Profitability is solid with margins at 29.3% and operating margin at 29.6%. Revenue growth of 17.6% demonstrates continued momentum.

Bear Case : HSTM

The primary concerns for HSTM are Market Cap, Return on Equity, Profit Margin. A P/E of 41.1x leaves little room for execution misses.

Bear Case : VEEV

The primary concerns for VEEV are P/E Ratio. A P/E of 42.7x leaves little room for execution misses.

Key Dynamics to Monitor

HSTM profiles as a value stock while VEEV is a growth play — different risk/reward profiles.

VEEV carries more volatility with a beta of 0.97 — expect wider price swings.

VEEV is growing revenue faster at 17.6% — sustainability is the question.

VEEV generates stronger free cash flow (231M), providing more financial flexibility.

Bottom Line

VEEV scores higher overall (66/100 vs 53/100), backed by strong 29.3% margins and 17.6% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

HealthStream Inc

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

HealthStream, Inc. provides provider and staff solutions for healthcare organizations in the United States. The company is headquartered in Nashville, Tennessee.

Visit Website →

Veeva Systems Inc Class A

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, Asia Pacific, the Middle East, Africa, and Latin America. The company is headquartered in Pleasanton, California.

Visit Website →

Want to dig deeper into these stocks?